FONAR CORP. NEW DL-0001
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company of… Read more
FONAR CORP. NEW DL-0001 (FOAA) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, FONAR CORP. NEW DL-0001 (FOAA) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
FONAR CORP. NEW DL-0001 - Net Assets Trend (None–None)
This chart illustrates how FONAR CORP. NEW DL-0001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for FONAR CORP. NEW DL-0001 (None–None)
The table below shows the annual net assets of FONAR CORP. NEW DL-0001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to FONAR CORP. NEW DL-0001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
FONAR CORP. NEW DL-0001 Competitors by Market Cap
The table below lists competitors of FONAR CORP. NEW DL-0001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Anadolu Hayat Emeklilik Anonim Sirketi
PINK:AUHYF
|
$90.55 Million |
|
China New Higher Education Group Limited
F:8CN
|
$90.56 Million |
|
Medigen Biotechnology
TWO:3176
|
$90.59 Million |
|
CARECLOUD INC. DL-001
F:MTB0
|
$90.61 Million |
|
SIEM OFFSHORE NEW DL 1
F:S5H0
|
$90.45 Million |
|
Good Will Instrument Co Ltd
TW:2423
|
$90.45 Million |
|
Yummies Inc
PINK:YUMM
|
$90.44 Million |
|
Dmc Global Inc
NASDAQ:BOOM
|
$90.42 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in FONAR CORP. NEW DL-0001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares FONAR CORP. NEW DL-0001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently FONAR CORP. NEW DL-0001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares FONAR CORP. NEW DL-0001's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $10,792,710,184
- Average return on equity (ROE) among peers: -33.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| FONAR CORP. NEW DL-0001 (FOAA) | €- | N/A | N/A | $90.54 Million |
| Spermosens AB (publ) (9R5) | $23.64 Million | -27.17% | 0.09x | $517.28K |
| BML Inc (BMZ) | $81.13 Billion | 8.19% | 0.43x | $462.01 Million |
| Genomic Vision Société Anonyme (G09) | $3.07 Million | -162.85% | 1.21x | $711.54K |
| ICON Public Limited Company (IJF) | $1.85 Billion | 17.96% | 0.86x | $6.43 Billion |
| Adicon Holdings Limited (K0U) | $1.77 Billion | 2.65% | 1.64x | $138.53 Million |
| WuXi XDC Cayman Inc. (L74) | $1.48 Billion | 10.52% | 0.69x | $2.11 Billion |
| NanoRepro AG (NN6) | $57.61 Million | 51.59% | 0.37x | $16.84 Million |
| PERRIGO (PGO) | $24.67 Million | -167.93% | 0.99x | $6.37K |